Lonza Group Ltd

Pharmaceuticals, Biotechnology and Life Sciences

Targets set1.5°C

SBTI ID

40014564

Informations générales

Localisation

Switzerland

Europe

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

Corporate

Dernière mise à jour

04/04/2024

Objectifs à court terme (Near-Term)
Engagement de réduction des émissions à horizon 2030

Statut

Targets set

Classification

1.5°C

Année cible

2030

Progression vers l'objectif73%
2015 (année de référence)2030
Description complète des objectifs

Lonza commits to reduce absolute scope 1 and 2 GHG emissions 42% by 2030 from a 2021 base year*. Lonza also commits that 79% of its suppliers by emissions covering purchased goods and services, capital goods and upstream transportation and distribution, will have science-based targets by 2028. *The target boundary includes biogenic land-related emissions and removals from bioenergy feedstocks.

Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Identifiants

ISIN

CH0013841017

LEI

549300EFW4H2TCZ71055

Source : Science Based Targets initiative | Données publiques